ISTAR-T: Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors

Sponsor
AdventHealth Translational Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT02859116
Collaborator
(none)
8
1
66
0.1

Study Details

Study Description

Brief Summary

The purpose of this study is to help scientists understand how the gut senses ingested nutrients and what kind of processes take place for their absorption in order to establish the association with diabetes and other metabolic diseases Scientists need human specimens to study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Collection of digestive tissues

Study Design

Study Type:
Observational
Actual Enrollment :
8 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors
Actual Study Start Date :
Jul 21, 2016
Actual Primary Completion Date :
Sep 12, 2018
Actual Study Completion Date :
Jan 21, 2022

Arms and Interventions

Arm Intervention/Treatment
Collection of digestive tissues

Digestive tissues will be collected from participants undergoing scheduled (non-emergent) gastrointestinal surgery.

Procedure: Collection of digestive tissues
The surgeon will resect a sample (approximately 1-5 cm x 1-5 cm) of healthy tissue from the distal margins of the segment and at least 4 cm from the diseased area. The specimen for research will be obtained from the tissue that would ordinarily be removed during surgery.The tissue collected for our research purposes will be only remnant tissue which is discarded by the surgeon during the surgical intervention and has no diagnostic clinical value.

Outcome Measures

Primary Outcome Measures

  1. Tissue collection [Day of surgery]

    During surgery, a tissue specimen that would normally be discarded, will be obtained and used to identify the localization and amount of different proteins that regulate nutrient absorption.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Men and women age 18 years and older who are having elective gastrointestinal surgery

  2. Able to provide written, informed consent

Exclusion Criteria:
  1. Unable to provide written, informed consent

  2. Use of antibiotics for more than 5 consecutive days in the three months prior to the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Translational Research Institute for Metabolism and Diabetes Orlando Florida United States 32804

Sponsors and Collaborators

  • AdventHealth Translational Research Institute

Investigators

  • Principal Investigator: Richard Pratley, MD, Study Principal Investigator

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
AdventHealth Translational Research Institute
ClinicalTrials.gov Identifier:
NCT02859116
Other Study ID Numbers:
  • TRIMD FH 794609
First Posted:
Aug 8, 2016
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by AdventHealth Translational Research Institute

Study Results

No Results Posted as of Aug 3, 2022